Switch to
More onapp

How to use scorecard? Learn more

GlaxoSmithKline Pharmaceuticals Ltd

GLAXO
Health CarePharmaceuticals
MidcapWith a market cap of ₹36,354 cr, stock is ranked 221
Moderate RiskStock is 2.48x as volatile as Nifty
2,146.0010.50 (+0.49%)

Price Chart

High
₹ 2,202.00
Low
₹ 2,110.10
Returns
0.49%
1D
1W
1M
1Y
5Y
Max
SIP
Prev. Close
₹ 2,135.50
09:16AM12:30PM03:29PM
1D
1W
1M
1Y
5Y
Max
SIP
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

PRO

Unlock deeper insights
for more calculated investments

Performance

Valuation

High

Seems to be overvalued vs the market average

PRO

Unlock deeper insights
for more calculated investments

Valuation

Growth

Low

Lagging behind the market in financials growth

PRO

Unlock deeper insights
for more calculated investments

Growth

Profitability

High

Showing good signs of profitability & efficiency

PRO

Unlock deeper insights
for more calculated investments

Profitability

Entry point

Good

The stock is underpriced and is not in the overbought zone

Fundamentals

Current price is less than the intrinsic value

Technicals

Good time to consider, stock is not in the overbought zone

Red flags

Low

No red flag found

ASM

Stock is not in ASM list

GSM

Stock is not in GSM list

Promoter pledged holding

Not a lot of promoter holding is pledged

Unsolicited messages

Default probability

How to use scorecard? Learn more

Health CarePharmaceuticals
MidcapWith a market cap of ₹36,354 cr, stock is ranked 221
Moderate RiskStock is 2.48x as volatile as Nifty

Key MetricsEdit

TTM PE RatioTTM PE Ratio

TTM PE Ratio

Close price divided by the TTM earnings per share, excluding extraordinary items. TTM stands for trailing twelve months.

53.86
PB RatioPB Ratio

PB Ratio

Close price divided by the book value per share at the end of the most recent financial year

20.45
Dividend YieldDiv. Yield

Dividend Yield

Dividend Per Share for the most recent financial year divided by the close price

1.49%
Sector PESector PE

Sector PE

Average PE ratio of the sector the stock belongs to

49.43
Sector PBSector PB

Sector PB

Average PB ratio of the sector the stock belongs to

6.41
Sector Div YldSctr Div Yld

Sector Div Yld

Average dividend yield of the sector the stock belongs to

0.54%

Forecast & RatingsDetailed Forecast 

50%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

GlaxoSmithKline Pharmaceuticals is a pharmaceutical company engaged in the business of manufacturing, distributing and trading in pharmaceuticals. The Co

Brands

Glaxosmithkline Pharma

Pharmaceutical company

Brands

Glaxosmithkline Pharma

Pharmaceutical company

Financial TrendFinancial statements 

20212022202320243.144.703.373.600.361.690.610.59
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent NewsAll news 

Hmm, looks like data is unavailable here. Please come back after some time
See all news

Recent EventsAll events 

Trading Window-XBRL 
Announced OnJan 20, 2025
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed th
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Closure of Trading Wi
Board Meeting Intimation 
Announced OnJan 20, 2025
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed th
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Board Meeting to be
Cash Dividend 
Ex. DateNov 7, 2024

Special • Div/Share: ₹ 12

See all events